Home NDC 59262-375-12 Dry Eye Relief
Product NDC 59262-375
Requested package NDC 59262-375-12
11-digit product format 592620375
Labeler code 59262
Product ID 59262-375_d5c9262c-2fe5-4492-a85a-1cab9de1126c
Type HUMAN OTC DRUG
Nonproprietary name Atropa Belladonna and Euphrasia Stricta and Mercuric Chloride
Dosage form SOLUTION/ DROPS
Route OPHTHALMIC
Labeler Similasan Corporation
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 2019-03-01
Marketing end 0000-00-00
Substance ATROPA BELLADONNA; EUPHRASIA STRICTA; MERCURIC CHLORIDE
Active strength 6 [hp_X]/.4mL; [hp_X]/.4mL; [hp_X]/.4mL
NDC exclude flag No
Listing certified through 2024-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 13 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Code, Status table Captured / source date Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…2022-08-30 03:57 UTC · source 2022-08-29 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 59262-375-12 Dry Eye Relief 20 in 1 CARTON SOLUTION/ DROPS 20 2 59262-375-12 Dry Eye Relief 0.4 mL in 1 VIAL, SINGLE-USE SOLUTION/ DROPS 0.4 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 59262-375 DRY EYE RELIEF (ATROPA BELLADONNA AND EUPHRASIA STRICTA AND MERCURIC CHLORIDE) SOLUTION/ DROPS [SIMILASAN CORPORATION] 2 Legacy NDC, 2 package rows 20230106_a4579e36-a2b9-45c1-9b26-9c437d129d47.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 59262-375-12 59262037512 20 VIAL, SINGLE-USE in 1 CARTON (59262-375-12) > .4 mL in 1 VIAL, SINGLE-USE 2019-03-01 0000-00-00 No No Current